Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mylan, Biocon Launch Trastuzumab Biosimilar, Ogivri in the U.S.

americanpharmaceuticalreviewDecember 30, 2019

Tag: Mylan , Biocon , Ogivri , TRASTUZUMAB , Herceptin

PharmaSources Customer Service